Unlocking the Potential of 3rd Generation CARs with Dual Co-Stimulation

• Showcase the unique design of the only 3rd generation CAR with CD19 targeting plus CD28 and CD137 co-stimulatory domains
• Discuss clinical insights on safety and efficacy

New Data

Speakers:

Anita Schmitt

Deputy Head, Cellular Immunotherapy

Heidelberg University Hospital